Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Streptococcus infects humans by thwarting blood clotting

27.08.2004


Streptococcal bacteria may infect humans by using a bacterial enzyme to "hijack" the blood-clotting system, according to new research by Howard Hughes Medical Institute scientists.



In studies published in the August 27, 2004, issue of the journal Science, the researchers establish that the enzyme streptokinase is responsible for the pathogen’s ability to infect humans while exhibiting little activity against other mammals.

The scientists genetically altered strains of mice to make the animals susceptible to infection by streptococcus. They say their strategy outlines a new path for developing animal models for human-specific microbes. The research is also likely to open the way to new understanding of the factors that enable bacteria to evolve host specificity, the researchers said.


Howard Hughes Medical Institute investigator David Ginsburg led the research team, which included lead author Hongmin Sun and colleagues at the University of Michigan and Lund University in Sweden. "Understanding why bacteria in general are so species-specific has been a major problem for a long time," said Ginsburg. "And this species-specificity had greatly hindered our ability to develop an animal model for human-specific bacteria such as Group A streptococci, which are an important human pathogen."

Ginsburg said that Hongmin Sun’s achievement of constructing a transgenic mouse susceptible to streptococcus infection represents a major step not only in understanding infection by that bacterium, but in opening the way to similar studies of other bacteria.

In infecting its human host, the group A streptococcus secretes its own streptokinase, which activates the human form of the enzyme, plasminogen. Plasminogen, in turn, dissolves blood clots by degrading the protein, fibrin. A major question was what role streptokinase played in the bacterium’s overall pathogenicity, said Ginsburg.

To develop the "humanized" mouse that would be vulnerable to bacterial streptokinase, Sun attached the gene for human plasminogen to a regulatory DNA sequence that normally activates the gene for a mouse blood protein, albumin. This protein is produced in large amounts in the animal. The result was a transgenic mouse that made significant amounts of human plasminogen.

To show that the human plasminogen was functional in the mice, Sun crossed the transgenic mice with another strain in which their own plasminogen genes had been deleted. This cross essentially restored plasminogen function in the resulting mice. In test-tube experiments, Sun also demonstrated that streptokinase acted on the human plasminogen from the transgenic mice to dissolve blood clots just as if it were acting on a human clot.

"The critical experiment, though, was when Hongmin infected the skin of these transgenic mice with the group A streptococcus bacteria," said Ginsburg. "She found that the bacteria were much, much more toxic to these mice than the normal mice. This fit with the idea that streptokinase was an important component of the pathogenicity of strep. "I didn’t really think that this would work, because it seemed unlikely that, since pathogenicity seemed to be such a complex process, one factor could have such a dramatic effect by itself," he said.

In further experiments, the researchers found that when they removed the streptokinase gene from group A streptococci bacteria, there was little difference in their infectivity between normal and the transgenic mice.

Such studies have led Ginsburg and his colleagues to theorize that streptokinase "hijacks" the human clot-forming system for the bacteria’s own infective ends. "The theory is that the bacteria cause a local infection and begin to grow. Many of the bacterial products, as well as our immune cells, trigger the human clotting system, which evolved in part as a defense against such infection," said Ginsburg. "This system produces clots in the blood vessels around the infection, closing the highways that the bacteria would use to spread. However, the bacterial streptokinase bypasses this system causing the blood clot to dissolve so the bacteria can spread."

Sure enough, when the researchers bypassed the clotting defense by injecting the streptococcus directly into the bloodstream of both normal and transgenic mice, they both showed similar susceptibility to infection. In another experiment to demonstrate the defensive importance of the clotting system, the researchers administered a substance derived from snake venom that degrades another clotting protein, fibrinogen, discovering that the treatment greatly increased the mice’s mortality from this streptococcus infection.

Streptokinase’s importance to group A streptococci may generalize to many other human-specific bacteria that have evolved their own distinctive plasminogen-activating enzymes, said Ginsburg. Also, he said, the findings highlight the evolutionary arms race between bacteria and humans. "Clearly, if we could mutate our plasminogen so it still worked, yet was resistant to a bacterial streptokinase, it would give us an advantage," said Ginsburg. "But then the bacteria could mutate their streptokinase to keep up. So, you can see how one bacterial species and one host get locked in this evolutionary dance and would evolve apart from other host-bacterial pairs -- ending up with a multitude of variants of streptococci, one for each host. "This evolutionary mechanism probably functions for many other pathogenicity factors, not just streptokinase, and probably underlies the species-specificity of all kinds of infectious organisms," said Ginsburg.

Such findings also hint that subtle variations in plasminogen genes among humans could partially explain differences in susceptibility to certain infection in different people. Thus, he said, his laboratory is exploring the genetic variations in the blood-clotting system that might affect risk factors for infection. "Although this is speculation at this point, it might ultimately be possible to tailor treatment of infections to the pattern of genetic variability in clotting genes or other pathogenicity factors," said Ginsburg.

Jim Keeley | EurekAlert!
Further information:
http://www.hhmi.org

More articles from Life Sciences:

nachricht Topologische Quantenchemie
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

nachricht Topological Quantum Chemistry
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>